Back to search results

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Amyloid Plaque · Beta-Amyloid · DSAD · Prodromal Alzheimer's Disease · Alzheimer's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Barrow Neurological Institute, Phoenix, Arizona, United States

  • K2 Medical Research The Villages LLC, Lady Lake, Florida, United States

  • Charter Research, LLC, Orlando, Florida, United States

  • Headlands Horizons LLC, Orlando, Florida, United States

  • Charter Research, LLC, The Villages, Florida, United States

  • Indiana University / IU Health, Indianapolis, Indiana, United States

  • University of Kansas Medical Center Research Institute, Fairway, Kansas, United States

  • Massachusetts General Hospital, Boston, Massachusetts, United States

  • The Washington University, St Louis, Missouri, United States

  • Flourish Research, Matthews, North Carolina, United States

  • Neurology Clinical, P.C., Cordova, Tennessee, United States

  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

  • UT Health San Antonio, San Antonio, Texas, United States

  • Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain

  • Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  • Hospital Universitario Virgen De Las Nieves, Granada, Spain

  • Hospital Clínico San Carlos, Madrid, Spain

  • Hospital Universitario de la Princesa, Madrid, Spain

  • Hospital Universitario Marqués de Valdecilla, Santander, Spain

  • Hospital Universitario y Politécnico La Fe, Valencia, Spain

  • Cambridge and Peterborough NHS Foundation Trust - Windsor Research Units, Cambridge, United Kingdom

  • Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom

  • Re:Cognition Health Limited, London, United Kingdom

  • South London and Maudsley NHS Foundation Trust of The Maudsley Hospital, London, United Kingdom

  • Oxford Health NHS Foundation Trust, Oxford, United Kingdom

  • NeuroClin Limited, Warrington, United Kingdom

Study leads

  • Michael Rafii, MD

    Principal Investigator

    University of Southern California, Alzheimer's Therapeutic Research Institute, 9860 Mesa Rim Rd, San Diego, CA 92121, USA

View source on ClinicalTrials.gov(opens in a new tab)